Biopharmaceutical companies worldwide are bracing for an intense battle to take a share of the market dominated by Janssen's Stelara (ustekinumab), a monoclonal antibody recognized for its selective inhibition of cytokines L-12 or IL-23 to treat autoimmune diseases.First approved by the U.S. Food an
Korea ranked third behind China and the United States in the number of medical papers retracted for ethical reasons, according to a new study.A team of researchers from Kahramanmaraş Sütçü İmam University in Turkiye and the South Kazakhstan Medical University recently published their findings in the
Seoul National University Bundang Hospital (SNUBH) and Caremind, a local healthcare company, have initiated a national project aimed at developing a digital recovery room tailored for breast cancer patients who undergo breast reconstruction surgery.SNUBH Professor Jeong Jae-hoon from the Department
One in four Koreans experiences mental illness at least once in their lives.Still, the share of mental health outlay in the government’s total healthcare budget falls far short of the 5 percent, as recommended by the World Health Organization, according to a report.Rep. Kang Eun-mi, a member of the
The Korea Disease Control and Prevention Agency (KDCA) is contemplating the inclusion of a national immunization program (NIP) for shingles and is also examining the possibility of extending the human papillomavirus (HPV) vaccination, currently available to female adolescents to their male counterpa
Hanall Biopharma and Daewoong Pharmaceutical have entered clinical trials for their new pipeline, targeting the 10 trillion won ($7.46 billion) global Parkinson's disease treatment market.Hanall, Daewoong, and NurrOn Pharmaceuticals said Thursday that they have completed the first dosing of patients
MSD Korea's application for a bulk reimbursement expansion for 13 indications of Keytruda (pembrolizumab) has been rejected at the first threshold.On Wednesday, the Health Insurance Review and Assessment Service (HIRA) released the results of its deliberations on the reimbursement standards for drug
A team of National Cancer Center (NCC) researchers has identified a novel microRNA regulatory protein critical to the development and progression of malignant brain tumors that remain incurable.The team, led by Professors Kim Jong-heon and Park Jong-bae at the hospital, identified the precise mechan
Korean individuals with type 1 diabetes are pushing back against the decision to suspend the domestic sales of EOPatch, a wearable insulin pump product made by EOFlow embroiled in a patent suit in the U.S.A patient organization has filed an amicus brief with a U.S. court seeking to overturn the ban.
As SK chemicals moves forward with the sale of its pharmaceutical division, labor unions have declared their opposition to the sale.The union has made clear its opposition to the sale, saying that workers will have to bear the brunt of the restructuring and damages caused by the planned sale.SK chem
In the demanding terrain of pharmaceutical research and development (R&D), allegations from Rep. Kim Yeung-shik of the ruling People Power Party during the National Assembly's audit, scrutinizing Celltrion's Regkirona, its Covid-19 treatment, as an unsuccessful development, demands a balanced examin
DuchemBio announced on Thursday that it has obtained a license from the Korea Institute of Nuclear Safety (KINS) for a recovery and refining facility to recycle oxygen-18 (O-18) concentrate, successfully achieving the localization of a key material for radiopharmaceuticals that were previously entir
One Korean patient was prescribed over 10,000 tablets of nine different narcotics at a single hospital in a single day, government data showed. Experts are calling for the regulator’s tighter control over narcotic drugs. According to the data by the Ministry of Food and Drug Safety (MFDS) submitted
Samjin Pharmaceutical and AriBio are accelerating clinical trial preparations to develop a homegrown dementia treatment.Samjin and AriBio said Wednesday that they completed an expert meeting, "POLARIS AD AR1001 Global PⅢ Trial Meeting," last Friday and Saturday ahead of the domestic phase 3 clinical
Minister of Health and Welfare Cho Kyoo-hong said there is no specific timeline for expanding the medical school enrollment quota, but "the announcement could come early."Cho made the remark in response to a question from Rep. Kim Won-i of the Democratic Party of Korea at the National Assembly's min
People with age-related macular degeneration, a common cause of blindness in older adults, have a significantly increased risk of fractures, according to a new study.Macular degeneration typically occurs in people over 50. Unlike blurred vision in older people, it is characterized by symptoms such a
Local diabetes experts from the Korean Diabetes Association (KDA) emphasized the urgent need for government support in diabetes education as the nation experiences a surge in diabetic patients due to Westernized eating habits and various other factors.Speaking at the "2023 KDA Autumn Press Conferenc
CanariaBio, a Korean biotech company listed on Kosdaq, said it has entered into an exclusive distribution and license agreement with Hikma MENA FZE for the commercialization of oregovomab, an immunotherapy for ovarian cancer, in the Middle East and North Africa (MENA) region.Hikma MENA FTZ, which wi
A series of recent drug mispackaging incidents have put the manufacturing process management of domestic pharmaceutical companies under scrutiny.This time, the mix-up incident involved a dyslipidemia drug produced by Daewon Pharmaceutical. The incident's aftermath will be closely watched as Daewon p
Korean and foreign pharma and biotech experts recently gathered to discuss strategies to reverse the current downturn in the industry.The 2023 KoNECT International Conference (KIC) was held at the Conrad Hotel in Yeouido, Seoul, on Tuesday. Co-hosted by the Korea National Enterprise for Clinical Tri